GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Short Interest

Biovica International AB (OSTO:BIOVIC B) Short Interest


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Biovica International AB's Short Interest

For the Biotechnology subindustry, Biovica International AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biovica International AB's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Short Interest falls into.


;
;

Biovica International AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Short Interest
Comparable Companies
OSTO:ONCOZ OSTO:2CUREX OSTO:PILA OSTO:ACOU OSTO:EXPRS2 OSTO:NICA XSAT:ABERA OSTO:NXTCL OSTO:SIMRIS B OSTO:LARK VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
9II:Germany
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Website
https://www.biovica.com
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines